NATURAL ALTERNATIVES INTERNATIONAL, INC.

Natural Alternatives International, Inc.

NAII

US6388423021

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.25 ^USD	-3.40%		-6.44%	-4.29%

Apr. 02	Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs	CI
Feb. 15	CarnoSyn®? Brands Partners with Barentz for Exclusive Brazilian Distribution of CarnoSyn®? Beta-Alanine	CI

Natural Alternatives International Inc. announces an Increase in Equity Buyback.

December 04, 2022

On December 5, 2022, the company announced an increase in its equity buyback plan. The company increased its authorization by $1 million thereby bringing the total authorization to $19 million.

Latest news about Natural Alternatives International, Inc.

Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs	Apr. 02	CI
CarnoSyn®? Brands Partners with Barentz for Exclusive Brazilian Distribution of CarnoSyn®? Beta-Alanine	Feb. 15	CI
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q2 Revenue $25.2M	Feb. 13	MT
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q1 Revenue $34M	Nov. 09	MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011.	Nov. 09	CI
Natural Alternatives International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 09	CI
North American Morning Briefing : Yield Surge -2-	23-09-26	DJ
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q4 Revenue $35.9M	23-09-21	MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011.	23-09-21	CI
Natural Alternatives International, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-09-21	CI
North American Morning Briefing : Stock Futures -2-	23-09-19	DJ
Natural Alternatives Temporarily Shuts New Facility in California; Staff Furlough Notice Issued; Shares Drop After Hours	23-08-16	MT
Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs	23-08-16	CI
Natural Alternatives International Appoints Shane Conti as New VP of Global Sales	23-07-25	CI
Natural Alternatives International, Inc. Enters into A Fourth Amendment to Lease Amending and Extending the Term of the Lease of Its Vista California Manufacturing Facilities	23-07-24	CI
Natural Alternatives International Adds New Manufacturing Unit in California	23-05-24	MT
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q3 Revenue $32.7M	23-05-15	MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011.	23-05-15	CI
Natural Alternatives International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
North American Morning Briefing : Hopes of Easing -2-	23-05-12	DJ
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Posts Q2 Revenue $42.3M	23-02-08	MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011.	23-02-08	CI
Natural Alternatives International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-08	CI
Natural Alternatives International Inc. announces an Increase in Equity Buyback.	22-12-04	CI
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Posts Q1 Revenue $43.1M	22-11-09	MT

Chart Natural Alternatives International, Inc.

Duration

Period

Chart Natural Alternatives International, Inc.

More charts

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Companyâs CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NATURAL ALTERNATIVES INTERNATIONAL, INC.	-4.29%	38.06M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B